Verano Holdings Analysis: Why VRNOF Scores 74/100 (BUY)
TL;DR Verano Holdings (VRNOF) earns a BUY rating with a score of 74/100. With 28% YoY revenue growth, expanding 46% gross margins, and EBITDA positive for 4 consecutive quarters, Verano is positioned as a top pick in the cannabis sector. NJ recreational market launch provides near-term catalysts. TIER 1 – Business Fundamentals Score: 78/100 | […]
Why MSO Valuations Are Outperforming Despite Revenue Headwinds
By Sheeba M. | April 20, 2026 Why MSO Valuations Are Outperforming Despite Revenue Headwinds TL;DR: Multi-state operators are trading at premium multiples even as top-line growth stagnates—smart money is betting on margin expansion and eventual federal reclassification catalysts. In a year where most cannabis operators are reporting flat to negative revenue growth, the sector’s […]
Cannabis Banking Reform Gains Momentum as Senate Committee Advances SAFE Plus
By Sheeba M. | April 20, 2026 Cannabis Banking Reform Gains Momentum as Senate Committee Advances SAFE Plus TL;DR: The Senate Banking Committee’s advancement of SAFE Plus marks the strongest legislative signal yet for cannabis banking reform—but operators should brace for a long wait before any meaningful change reaches bank accounts. The cannabis industry’s decades-long […]
Florida’s Adult-Use Launch Could Make Trulieve the Quiet Winner of 2026
By Sheeba M. | April 19, 2026 Florida’s Adult-Use Launch Could Make Trulieve the Quiet Winner of 2026 TL;DR: Florida’s Amendment 3 passed with 60%+ support, and Trulieve — the state’s largest MMTC with 130+ dispensaries — is positioned to capture the lion’s share of adult-use revenue when sales go live. The stock is up […]
MSOS ETF Inflows Signal Wall Street Is Done Waiting on Cannabis
By Sheeba M. | April 19, 2026 MSOS ETF Inflows Signal Wall Street Is Done Waiting on Cannabis TL;DR: The AdvisorShares Pure Cannabis ETF (MSOS) posted its largest weekly inflow since 2021, a clear signal that institutional capital is positioning ahead of potential rescheduling. MSOS holds multi-state operators like Curaleaf and Verano — positions that […]
Green Thumb Industries vs. Cresco Labs: Mid-Tier MSO Showdown After Q1 2026 Earnings Season
By Sheeba M. | April 19, 2026 Green Thumb Industries vs. Cresco Labs: Mid-Tier MSO Showdown After Q1 2026 Earnings Season TL;DR: Both Green Thumb and Cresco Labs beat Q1 estimates, but their paths are diverging — GTBIF is doubling down on retail branding while CRLBF is chasing wholesale scale. The smarter bet in 2026: […]
Verano Holdings Posts Q1 2026: $280M Revenue and the Path to Becoming the US’s #2 Cannabis Operator
By Sheeba M. | April 19, 2026 Verano Holdings Posts Q1 2026: $280M Revenue and the Path to Becoming the US’s #2 Cannabis Operator TL;DR: Verano’s Q1 2026 numbers confirm the MSO is firing on all cylinders — $280M in revenue, positive EBITDA, and aggressive store growth. With recent acquisitions stacking its footprint, VRNO may […]
Bipartisan Senate Bill Could Shield Hemp THC Products — And Reshape the Cannabis Market
By Sheeba M. | April 19, 2026 Bipartisan Senate Bill Could Shield Hemp THC Products — And Reshape the Cannabis Market TL;DR: A new bipartisan Senate bill would let states opt out of a federal crackdown on hemp-derived THC products. If passed, it protects the booming delta-8 and hemp THC market — and removes a […]
Tilray Brands Posts Record Q3 Fiscal 2026: $207 Million Revenue Signals MSO Turnaround Is Real
By Sheeba M. | April 19, 2026 Tilray Brands Posts Record Q3 Fiscal 2026: $207 Million Revenue Signals MSO Turnaround Is Real TL;DR: Tilray just posted $207 million in Q3 fiscal 2026 revenue — a new record. With 11% organic growth and expanding gross margins, the Canadian giant is proving that scale + efficiency = […]
Cannabis Rescheduling Update: What the DEA’s Latest Move Actually Means for Your Stocks
By Sheeba M. | April 18, 2026 Cannabis Rescheduling Update: What the DEA’s Latest Move Actually Means for Your Stocks TL;DR: The DEA’s proposed rescheduling to Schedule III is real progress, but it doesn’t solve the core banking, tax, or listing problems cannabis companies face. Here’s what actually changes — and what doesn’t. After years […]